In-Depth Examination Of 11 Analyst Recommendations For Teladoc Health
Portfolio Pulse from Benzinga Insights
Teladoc Health (NYSE:TDOC) has been analyzed by 11 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target has decreased by 36.16% to $10.91. Analysts have mostly lowered their ratings and price targets, reflecting concerns about Teladoc's financial performance, including revenue decline, negative net margin, and high debt-to-equity ratio.
August 20, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Teladoc Health has received mixed analyst ratings, with a significant drop in the average price target. Analysts have mostly lowered their ratings, reflecting concerns about the company's financial performance, including revenue decline, negative net margin, and high debt-to-equity ratio.
The majority of analysts have lowered their ratings and price targets for Teladoc Health, indicating a negative sentiment. The company's financial challenges, such as declining revenue, negative net margin, and high debt levels, contribute to this outlook. The significant drop in the average price target further supports a likely short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100